Challenges in the development of a survivin vaccine (SurVaxM) for malignant glioma

Treat cancers by targeting survivin: Just a dream or future reality?

(2013) Mohane Selvaraj Coumar et al.   CANCER TREATMENT REVIEWS

Enhancement of survivin-specific anti-tumor immunity by adenovirus prime protein-boost immunity strategy with DDA/MPL adjuvant in a murine melanoma model

(2013) Yu-Qian Wang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients

(2013) Laura Ridolfi et al.   Journal of Translational Medicine

Concomitant combination of active immunotherapy and carboplatin- or paclitaxel-based chemotherapy improves anti-tumor response

(2012) Y. Diaz et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Harmonization of the intracellular cytokine staining assay

(2012) Marij J. P. Welters et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immunotherapy for the Treatment of Glioblastoma

(2012) Alissa A. Thomas et al.   CANCER JOURNAL

The Spectrum of Vaccine Therapies for Patients With Glioblastoma Multiforme

(2012) Laura K. Aguilar et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009

(2012) T. A. Dolecek et al.   NEURO-ONCOLOGY

Impact of tumour volume on the potential efficacy of therapeutic vaccines

(2011) J. L. Gulley et al.   Current Oncology

Antitumor cytotoxic T-cell response induced by a survivin peptide mimic

(2010) Michael J. Ciesielski et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model

(2009) Claire Banissi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immunological Factors Relating to the Antitumor Effect of Temozolomide Chemoimmunotherapy in a Murine Glioma Model

(2009) T.-G. Kim et al.   Clinical and Vaccine Immunology

“MIATA”—Minimal Information about T Cell Assays

(2009) Sylvia Janetzki et al.   IMMUNITY

Balancing between Antitumor Efficacy and Autoimmune Pathology in T-Cell-Mediated Targeting of Carcinoembryonic Antigen

(2008) R. Bos et al.   CANCER RESEARCH